MedTrace Logo

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract

NCT05432245 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-02-28

No results posted yet for this study

Summary

The study will assess safety and performance of MINIject implant in patients with open-angle glaucoma uncontrolled by topical hypotensive medications in conjunction with cataract surgery.

Conditions

  • Primary Open-angle Glaucoma
  • Cataract

Interventions

DEVICE

Phacoemulsification combined with minimally invasive glaucoma surgery (MIGS)

The cataract surgery will be performed first and if successful, only then will the MINIject be placed into supraciliary space.

Sponsors & Collaborators

  • iSTAR Medical

    lead INDUSTRY

Principal Investigators

  • Zubair Hussain, PhD · iSTAR Medical

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-18
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Panama
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432245 on ClinicalTrials.gov